Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Nov 3, 2022

Mark Manfredi is the CEO and President of Ikena Oncology, which is exploring the Hippo Pathway and how it relates to the RAS Pathway and RAS Network in order to inhibit genes that are associated with cancer initiation, progression, and cancer cell survival. Ikena is learning a great deal about drugging these pathways...


Nov 3, 2022

Mark Manfredi is the CEO and President of Ikena Oncology, which is exploring the Hippo Pathway and how it relates to the RAS Pathway and RAS Network in order to inhibit genes that are associated with cancer initiation, progression, and cancer cell survival. Ikena is learning a great deal about drugging these pathways...


Sep 27, 2022

Jack Hoppin Ph.D. Chief Executive Officer and John Babich Ph.D., President and Chief Scientific Officer, and Co-Founders of Ratio Therapeutics aim to develop and produce best-in-class radiopharmaceuticals. Harnessing the power of radiation by making it into an injectable drug, Ratio is creating a way to find tumor cells...


Sep 27, 2022

Jack Hoppin Ph.D. Chief Executive Officer and John Babich Ph.D., President and Chief Scientific Officer, and Co-Founders of Ratio Therapeutics aim to develop and produce best-in-class radiopharmaceuticals. Harnessing the power of radiation by making it into an injectable drug, Ratio is creating a way to find tumor cells...


Sep 22, 2022

Dr. Robert Ross is the CEO of Surface Oncology, which is focused on immune modulation in the treatment of cancers. Their hypothesis is that IL-27, a cytokine, is telling the immune system to ignore the cancer and providing a hiding place for the cancer cells. By administering their drug SRF 388 to bind up all the IL-27,...